Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells. Clinics [Internet]. 2012 Sep. 1 [cited 2024 Apr. 28];67(9):1093-9. Available from: https://www.revistas.usp.br/clinics/article/view/45877